Close

News

AstraZeneca initiates phase III clinical programme evaluating NKTR-118

AstraZeneca announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment of opioid-induced constipation (OIC). The Phase III clinical programme is designed to investigate the...

Lilly Announces New Vice President of Oncology Research

Eli Lilly and Company announced that Greg Plowman, M.D., Ph.D., will lead Lilly's oncology research efforts as the vice president, oncology research and senior vice president of ImClone Systems research. In this innovative new role created...

Amgen Donates $1 Million to Help Japanese Disaster Victims

Amgen announced that the company will donate $1 million to Japanese disaster relief efforts. Amgen and the Amgen Foundation will distribute the funds to both Direct Relief International and International Medical Corps to bring basic needs and vital health...

Takeda’s Donation to Aid Earthquake Relief Efforts in Japan

Takeda Pharmaceutical Company Limited announced 300 million Japanese yen donation to aid emergency relief for the earthquake on March 11, through The Japanese Red Cross Society, in view of the huge damages in the wide geographical area affected in...

Bristol-Myers Squibb Foundation Announces Funding of Nearly $1 Million to China & India

The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B (HBV) and hepatitis C (HCV) in China and India. The grants total nearly $1 million USD and bring the Foundation’s...

Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.

Pfizer Inc. announced that it has combined operations with King Pharmaceuticals, Inc. On February 28, 2011, Pfizer completed its acquisition of King through the merger of its wholly owned subsidiary, Parker Tennessee Corp., with and into King. King is...

Pharma Idol Winner Announced

Since launching in November, eyeforpharma's Pharma Idol competition has caused quite a stir in the industry and not just due to the launch video featuring many of eyeforpharma's key personell. http://www.eyeforpharma.com/sales/pharma-idol.shtmlThe competition was unique as it...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read